Body mass index, waist circumference and mortality in kidney transplant recipients

American Journal of Transplantation

Volumn 10, Issue 12, 2010, Pages 2644-2651

  Kovesdy, C P ^a,b   Czira, M E ^c   Rudas, A ^c   Ujszaszi, A ^c   Rosivall, L ^c   Novak, M ^c,d   Kalantar Zadeh, K ^e   Molnar, M Z ^c,e   Mucsi, I ^c,f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e HARBOR UCLA MEDICAL CENTER   (United States)

^f MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

body mass index; kidney transplant; mortality; waist circumference

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GRAFT RECIPIENT; HAZARD RATIO; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; WAIST CIRCUMFERENCE;

ADULT; AGED; BODY MASS INDEX; CAUSE OF DEATH; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OBESITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; WAIST CIRCUMFERENCE;

EID: 78649845904     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03330.x     Document Type: Article

References (51)

1. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL,. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994; 272: 205-211.
2. Byers T,. Body weight and mortality. N Engl J Med 1995; 333: 723-724.
3. Hsu C, McCulloch C, Iribarren C, Darbinian J, Go A,. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28.
4. Lew EA, Garfinkel L,. Variations in mortality by weight among 750,000 men and women. J Chronic Dis 1979; 32: 563-576.
5. Manson JE, Willett WC, Stampfer MJ, et al,. Body weight and mortality among women. N Engl J Med 1995; 333: 677-685.
6. Pischon T, Boeing H, Hoffmann K, et al,. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359: 2105-2120.
7. National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. National Institutes of Health. Obes Res 1998; 6 (Suppl 2): 51S-209S.
8. Curtis JP, Selter JG, Wang Y, et al,. The obesity paradox: Body mass index and outcomes in patients with heart failure. Arch Intern Med 2005; 165: 55-61.
9. Wilson DO, Rogers RM, Wright EC, Anthonisen NR,. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 1989; 139: 1435-1438.
10. Escalante A, Haas RW, Del R, I,. Paradoxical effect of body mass index on survival in rheumatoid arthritis: Role of comorbidity and systemic inflammation. Arch Intern Med 2005; 165: 1624-1629.
11. Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ,. Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis 1998; 31: 997-1006.
12. Glanton CW, Hypolite IO, Hshieh PB, Agodoa LY, Yuan CM, Abbott KC,. Factors associated with improved short term survival in obese end stage renal disease patients. Ann Epidemiol 2003; 13: 136-143.
13. Johansen KL, Kutner NG, Young B, Chertow GM,. Association of body size with health status in patients beginning dialysis. Am J Clin Nutr 2006; 83: 543-549.
14. Kalantar-Zadeh K, Kuwae N, Wu DY, et al,. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 2006; 83: 202-210.
15. Leavey SF, McCullough K, Hecking E, Goodkin D, Port FK, Young EW,. Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2001; 16: 2386-2394.
16. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA,. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 2002; 13: 1061-1066.
17. Wolfe RA, Ashby VB, Daugirdas JT, Agodoa LY, Jones CA, Port FK,. Body size, dose of hemodialysis, and mortality. Am J Kidney Dis 2000; 35: 80-88.
18. Beddhu S, Pappas LM, Ramkumar N, Samore M,. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 2003; 14: 2366-2372.
19. Kovesdy CP, Anderson JE, Kalantar-Zadeh K,. Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis 2007; 49: 581-591.
20. Holley JL, Shapiro R, Lopatin WB, Tzakis AG, Hakala TR, Starzl TE,. Obesity as a risk factor following cadaveric renal transplantation. Transplantation 1990; 49: 387-389.
21. Pirsch JD, Armbrust MJ, Knechtle SJ, et al,. Obesity as a risk factor following renal transplantation. Transplantation 1995; 59: 631-633.
22. Pischon T, Sharma AM,. Obesity as a risk factor in renal transplant patients. Nephrol Dial Transplant 2001; 16: 14-17.
23. Ghahramani N, Reeves WB, Hollenbeak C,. Association between increased body mass index, calcineurin inhibitor use, and renal graft survival. Exp Clin Transplant 2008; 6: 199-202.
24. Howard RJ, Thai VB, Patton PR, et al,. Obesity does not portend a bad outcome for kidney transplant recipients. Transplantation 2002; 73: 53-55.
25. Lentine KL, Rocca-Rey LA, Bacchi G, et al,. Obesity and cardiac risk after kidney transplantation: Experience at one center and comprehensive literature review. Transplantation 2008; 86: 303-312.
26. Johnson DW, Isbel NM, Brown AM, et al,. The effect of obesity on renal transplant outcomes. Transplantation 2002; 74: 675-681.
27. Massarweh NN, Clayton JL, Mangum CA, Florman SS, Slakey DP,. High body mass index and short- and long-term renal allograft survival in adults. Transplantation 2005; 80: 1430-1434.
28. Lynch RJ, Ranney DN, Shijie C, Lee DS, Samala N, Englesbe MJ,. Obesity, surgical site infection, and outcome following renal transplantation. Ann Surg 2009; 250: 1014-1020.
29. Bennett WM, McEvoy KM, Henell KR, Valente JF, Douzdjian V,. Morbid obesity does not preclude successful renal transplantation. Clin Transplant 2004; 18: 89-93.
30. Marks WH, Florence LS, Chapman PH, Precht AF, Perkinson DT,. Morbid obesity is not a contraindication to kidney transplantation. Am J Surg 2004; 187: 635-638.
31. Yusuf S, Hawken S, Ounpuu S, et al,. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: A case-control study. Lancet 2005; 366: 1640-1649.
32. Guallar-Castillon P, Balboa-Castillo T, Lopez-Garcia E, et al,. BMI, waist circumference, and mortality according to health status in the older adult population of Spain. Obesity (Silver Spring) 2009; 17: 2232-2238.
33. Postorino M, Marino C, Tripepi G, Zoccali C,. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 2009; 53: 1265-1272.
34. Molnar MZ, Keszei A, Czira ME, et al,. Evaluation of the malnutrition-inflammation score in kidney transplant recipients. Am J Kidney Dis 2010.
35. Hemmelgarn BR, Manns BJ, Quan H, Ghali WA,. Adapting the charlson comorbidity index for use in patients with ESRD. Am J Kidney Dis 2003; 42: 125-132.
36. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D,. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 1999; 130: 461-470.
37. Fine JP, Gray RJ,. A proportional hazards model for the subdistribution of competing risk. J Am Stat Assoc 1999; 94: 496-509.
38. Fine JP,. Regression modeling of competing crude failure probabilities. Biostatistics 2001; 2: 85-97.
39. Holley JL, Monaghan J, Byer B, Bronsther O,. An examination of the renal transplant evaluation process focusing on cost and the reasons for patient exclusion. Am J Kidney Dis 1998; 32: 567-574.
40. Scandling JD,. Kidney transplant candidate evaluation. Semin Dial 2005; 18: 487-494.
41. Kuk JL, Janiszewski PM, Ross R,. Body mass index and hip and thigh circumferences are negatively associated with visceral adipose tissue after control for waist circumference. Am J Clin Nutr 2007; 85: 1540-1544.
42. Kovesdy CP, Kalantar-Zadeh K,. Why is protein-energy wasting associated with mortality in chronic kidney disease? Semin Nephrol 2009; 29: 3-14.
43. Haslam DW, James WP,. Obesity. Lancet 2005; 366: 1197-11209.
44. Argiles JM,. Cancer-associated malnutrition. Eur J Oncol Nurs 2005; 9 (Suppl 2): S39-S50.
45. Lee PS, Waxman AB, Cotich KL, Chung SW, Perrella MA, Stossel TP,. Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit Care Med 2007; 35: 849-855.
46. Rothenbach PA, Dahl B, Schwartz JJ, et al,. Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction. J Appl Physiol 2004; 96: 25-31.
47. Christofidou-Solomidou M, Scherpereel A, Solomides CC, et al,. Recombinant plasma gelsolin diminishes the acute inflammatory response to hyperoxia in mice. J Investig Med 2002; 50: 54-60.
48. Lee PS, Sampath K, Karumanchi SA, et al,. Plasma gelsolin and circulating actin correlate with hemodialysis mortality. J Am Soc Nephrol 2009; 20: 1140-1148.
49. Haap M, Siewecke C, Thamer C, et al,. Multiple symmetric lipomatosis: A paradigm of metabolically innocent obesity? Diabetes Care 2004; 27: 794-795.
50. Lemieux I,. Energy partitioning in gluteal-femoral fat: Does the metabolic fate of triglycerides affect coronary heart disease risk? Arterioscler Thromb Vasc Biol 2004; 24: 795-797.
51. Snijder MB, Dekker JM, Visser M, et al,. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: The Hoorn study. Diabetes Care 2004; 27: 372-377.